Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis

Taro Yoshida; Hiroshi Sugahara; Keisuke Oikawa; Chinatsu Onodera; Manami Akasaka

doi:10.7759/cureus.102373

January 27, 2026CureusOpen Access

Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis

View Full Paper

Ask AI

Bookmark

Share

Key Points

Successful plasma exchange improved biomarkers in severe lupus nephritis.
After treatment, a notable reduction in proteinuria was observed within two weeks.
Case study detailing the treatment's efficacy in one pediatric patient with severe symptoms.
Highlights innovative treatment options, suggesting plasma exchange may enhance rituximab effectiveness.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Case study shows successful bridging to rituximab through plasma exchange in pediatric lupus nephritis, indicating potential for urgent therapeutic intervention.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yoshida et al. (2026) studied this question.

synapsesocial.com/papers/69a75a69c6e9836116a20337 https://doi.org/10.7759/cureus.102373

View Full Paper

Ask AI

Bookmark

Share

Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading